Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Upadacitinib in Adult and Adolescent Subjects With Alopecia Areata
NCT07023302Phase 3Active, not recruiting
- Sponsor
- AbbVie Inc.
- Start
- Jun 2025
- Primary completion
- Feb 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of upadacitinib in alopecia areata, sponsored by AbbVie Inc.. Started Jun 2025; status: active, not recruiting.
02
Drugs
upadacitinib
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT07023302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07023302.